Antitumor activity of titanocene Y in xenografted PC3 tumors in mice

Letters in Drug Design and Discovery

Volumn 5, Issue 2, 2008, Pages 141-144

  Dowling, Catherine M ^a   Claffey, James ^a   Cuffe, Sandra ^a   Fichtner, Iduna ^b   Pampillón, Clara ^a   Sweeney, Nigel J ^a   Strohfeldt, Katja ^a   Watson, R William G ^a   Tacke, Matthias ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Anti cancer drug; Cisplatin; PC 3; Prostate cancer; Titanocene; Xenograft

Indexed keywords

CISPLATIN; SOLVENT; TITANOCENE; TITANOCENE Y; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG SCREENING; IC 50; MALE; MAXIMUM TOLERATED DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; STATISTICAL SIGNIFICANCE; TUMOR XENOGRAFT;

EID: 41649104644     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018008783928463     Document Type: Article

References (38)

1. Hsing, A.W.; Tsao, L.; Devesa, S.S. Int. J. Cancer, 2000, 85, 60.
2. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.; Smigal, C.; Thun, T.J. CA Cancer J. Clin., 2006, 56, 106.
3. Petrylak, D.P.; Tangen, C.M.; Hussain, M.H.; Lara, P.N.Jr.; Jones, J.A.; Taplin, M.E.; Burch, P.A.; Berry, D.; Moinpour, C.; Kohli, M.; Benson, M.C.; Small, E.J.; Raghavan, D.; Crawford, E.D. N. Engl. J. Med., 2004, 351, 1513.
4. Tannock, I.F.; de Wit, R.; Berry, W.R.; Horti, J.; Pluzanska, A.; Chi, K.N.; Oudard, S.; Theodore, C.; James, N.D.; Turesson, I.; Rosenthal, M.A.; Eisenberger, M.A. N. Engl. J. Med., 2004, 351, 1502.
5. Schilling, T.; Keppler, B.K.; Heim, M.E.; Niebch, G.; Dietzfelbinger, H.; Rastetter, J.; Hanauske, A.R. Invest. New Drugs, 1996, 13, 327.
6. Melendez, E. Crit. Rev. Oncol./Hematol., 2002, 42, 309.
7. Caruso, F.; Rossi, M. Metal Ions in Biological Systems, 2004, 42, 353.
8. Lummen, G.; Sperling, H.; Luboldt, H.; Otto, T.; Rubben, H. Cancer Chemother. Pharmacol., 1998, 42, 415.
9. Kröger, N.; Kleeberg, U.R.; Mross, K.B.; Edler, L.; Saß, G.; Hossfeld, D.K. Onkol., 2000, 23, 60.
10. Allen, O.R.; Croll, L.; Gott, A.L.; Knox, R.J.; McGowan, P.C. Organometallics, 2004, 23, 288.
11. Causey, P.W.; Cole, S.P.C.; Baird, M.C. Organometallics, 2004, 23, 4486.
12. Meyer, R.; Brink, S.; van Rensburg, C.E.J.; Jooné G.K.; Görls, H.; Lotz, S. J. Organomet. Chem., 2005, 690, 117.
13. Fox, S.; Dunne, J.P.; Tacke, M.; Gallagher, J.F. Inorg. Chim. Acta, 2004, 357, 225.
14. Tacke, M.; Allen, L.T.; Cuffe, L.P.; Gallagher, W.M.; Lou, Y.; Mendoza, O.; Müller-Bunz, H.; Rehmann, F.-J. K.; Sweeney N. J. Organomet. Chem., 2004, 689, 2242.
15. Tacke, M.; Cuffe, L.P.; Gallagher, W.M.; Lou, Y.; Mendoza, O.; Müller-Bunz, H.; Rehmann, F.-J. K.; Sweeney N. J. Inorg. Biochem., 2004, 98, 1987.
16. Rehmann, F.-J.K., Rous, A.J.; Mendoza, O.; Pampillon, C.; Strohfeldt, K.; Sweeney, N.J.; Gallagher, W.M.; Tacke, M. Polyhedron, 2005, 24, 1250.
17. Rehmann F.-J.K.; Cuffe, L.P.; Mendoza, O.; Rai, D.K.; Sweeney, N.; Strohfeldt K.; Gallagher, W.M.; Tacke, M. Appl. Organomet. Chem., 2005, 19, 293.
18. Sweeney, N.J.; Mendoza, O.; Müller-Bunz, H.; Pampillón, C.; Rehmann, F.-J.K.; Strohfeldt, K.; Tacke, M. J. Organomet. Chem., 2005, 690, 4537.
19. Sweeney, N.J.; Gallagher, W.M.; Müller-Bunz, H.; Pampillón, C.; Strohfeldt, K.; Tacke, M. J. Inorg. Biochem., 2006, 100, 1479.
20. Strohfeldt, K.; Müller-Bunz, H.; Pampillón, C.; Sweeney, N.J.; Tacke, M. Eur. J. Inorg. Chem., 2006, 4621.
21. Sweeney, N.J.; Claffey, J.; Müller-Bunz, H.; Pampillón, C.; Strohfeldt, K.; Tacke, M. Appl. Organometal. Chem., 2007, 21, 57.
22. Pampillón, C.; Sweeney, N.J.; Strohfeldt, K.; Tacke, M. Inorg. Chim. Acta, 2006, 359, 3969.
23. Pampillón, C.; Mendoza, O.; Sweeney, N.J.; Strohfeldt, K.; Tacke, M. Polyhedron, 2006, 25, 2101.
24. Pampillón, C.; Sweeney, N.J.; Strohfeldt, K.; Tacke, M. J. Organomet. Chem., 2007, 692, 2153.
25. Pampillón, C.; Claffey, J.; Hogan, M.; Tacke, M. Z. Allg. Anorg. Chem., 2007, 633, 1695.
26. Pampillón, C.; Claffey, J.; Hogan, M.; Strohfeldt, K.; Tacke, M. Trans. Met. Chem., 2007, 32, 434.
27. Hogan, M.; Claffey, J.; Pampillón, C.; Watson, R.W.G.; Tacke, M. Organometallics, 2007, 26, 2501.
28. Hickey, T.; Claffey, J.; Fitzpatrick, E.; Hogan, M.; Pampillón, C.; Tacke, M. Invest. New Drugs, 2007, 25, 425.
29. Pampillón, C.; Claffey, J.; Hogan, M.; Tacke, M. BioMetals, 2008, http://dx.doi.org/10.1007/s10534-007-9108-5.
30. Pampillón, C.; Claffey, J.; Strohfeldt, K.; Tacke, M. Eur. J. Med. Chem., 2008, 43, 122.
31. Kelter, G.; Sweeney, N.; Strohfeldt, K.; Fiebig, H.H.; Tacke, M. Anti-Cancer Drugs, 2005, 16, 1091.
32. Oberschmidt, O.; Hanauske, A.R.; Rehmann, F.-J.K.; Strohfeldt, K.; Sweeney N.; Tacke, M. Anti-Cancer Drugs, 2005, 16, 1071.
33. Oberschmidt, O.; Hanauske, A.R.; Pampillón, C.; Sweeney, N.J.; Strohfeldt, K.; Tacke, M. Anti-Cancer Drugs, 2007, 18, 317.
34. O'Connor K.; Gill, C.; Tacke, M.; Rehmann, F.-J.K.; Strohfeldt, K.; Sweeney, N.; Fitzpatrick, J.M.; Watson, R.W.G. Apoptosis, 2006, 11, 1205.
35. Valadares, M.C.; Ramos, A.L.; Rehmann, F.J.K.; Sweeney, N.J.; Strohfeldt, K.; Tacke, M.; Queiroz, M.L.S. Eur. J. Pharmacol., 2006, 534, 264.
36. Fichtner, I.; Pampillón, C.; Sweeney, N.J.; Strohfeldt, K.; Tacke, M. Anti-Cancer Drugs, 2006, 17, 333.
37. Beckhove, P.; Oberschmidt, O.; Hanauske, A.R.; Pampillón, C.; Schirrmacher, V.; Sweeney, N.J.; Strohfeldt, K.; Tacke, M. Anti-Cancer Drugs, 2007, 18, 311.
38. Mosmann, T. J. Immunol. Methods, 1983, 65, 55.